Hasegawa Akihiro, Nakayama Toshinori
Department of Microbiology and Immunology, Graduate School of Medicine, Yamaguchi University.
Nihon Rinsho Meneki Gakkai Kaishi. 2010;33(4):189-95. doi: 10.2177/jsci.33.189.
CD69 is a type II membrane protein expressed as a homodimer composed of heavily glycosylated subunits. CD69 is known as an early activation marker antigen of lymphocytes,and its selective expression in inflammatory infiltrates suggests that it plays a role in the pathogenesis of inflammatory diseases. In order to address the role of CD69 in the pathogenesis of arthritis and allergic airway inflammation, we established CD69-deficient mice. CD69-deficient mice displayed a markedly attenuated arthritic inflammatory response and airway inflammation. The administration of anti-CD69 antibody inhibited the induction of the antigen-induced airway inflammation and hyperresponsiveness. These results indicate that CD69 plays a crucial role in the pathogenesis of arthritis and allergic airway inflammation and that CD69 could be a possible therapeutic target for arthritis and asthma in human patients.
CD69是一种II型膜蛋白,以由高度糖基化亚基组成的同型二聚体形式表达。CD69被认为是淋巴细胞的早期活化标志物抗原,其在炎症浸润中的选择性表达表明它在炎症性疾病的发病机制中起作用。为了研究CD69在关节炎和过敏性气道炎症发病机制中的作用,我们构建了CD69缺陷小鼠。CD69缺陷小鼠表现出明显减弱的关节炎炎症反应和气道炎症。抗CD69抗体的给药抑制了抗原诱导的气道炎症和高反应性的诱导。这些结果表明,CD69在关节炎和过敏性气道炎症的发病机制中起关键作用,并且CD69可能是人类患者关节炎和哮喘的潜在治疗靶点。